Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy

E Galli1, O A Smiseth2, J M Aalen2

  • 1Univ Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France.

Insights

Diastolic dysfunction (DD) grading in cardiac resynchronization therapy (CRT) candidates helps predict outcomes. Patients with grade I DD showed better prognosis, while non-responders with grade II-III DD faced worse outcomes.

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Management

Background:

  • Conflicting data exist regarding cardiac resynchronization therapy (CRT) effects on diastolic function.
  • Standardized assessment of diastolic patterns in CRT candidates is needed.
  • Evaluating the prognostic value of diastolic dysfunction (DD) in CRT candidates is crucial.

Purpose of the Study:

  • To assess diastolic patterns in patients undergoing CRT based on 2016 ASE/EACVI guidelines.
  • To determine the prognostic significance of diastolic dysfunction (DD) in CRT candidates.

Main Methods:

  • A multicentre prospective study included 193 patients (age 67 ± 11 years, QRS width 167 ± 21 ms).
  • Diastolic dysfunction (DD) was classified into grades I-III using mitral filling patterns, mitral tissue Doppler, tricuspid regurgitation velocity, and indexed left atrial volume.
  • CRT response was defined as >15% reduction in left ventricular end-systolic volume at 6-month follow-up.

Main Results:

  • CRT response occurred in 132 (68%) patients.
  • CRT was associated with diastolic dysfunction degradation in non-responders.
  • Grade I DD was linked to a better prognosis (HR 0.37), while grade II-III DD in non-responders indicated a worse prognosis (HR 4.36).

Conclusions:

  • Diastolic dysfunction assessment in CRT candidates provides independent prognostic stratification.
  • DD grading offers valuable insights into patient outcomes beyond CRT response.
  • This evaluation aids in personalized risk assessment for heart failure patients undergoing CRT.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
200
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
122
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
107